KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,886,000 | -95.8% | 27,840 | -96.8% | 0.43% | -95.6% |
| Q1 2017 | $69,059,000 | +33.7% | 879,840 | -23.6% | 9.77% | +11.5% |
| Q4 2016 | $51,635,000 | +37.6% | 1,151,540 | +71.5% | 8.76% | +28.0% |
| Q3 2016 | $37,512,000 | +3052.3% | 671,540 | +2722.8% | 6.85% | +2575.0% |
| Q2 2016 | $1,190,000 | +443.4% | 23,790 | +397.7% | 0.26% | +383.0% |
| Q1 2016 | $219,000 | -5.6% | 4,780 | +26.8% | 0.05% | +1.9% |
| Q4 2015 | $232,000 | – | 3,770 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|